Here are 4 of Jim Cramer’s top stock picks for 2022 — if you’re a risk-averse investor but still want solid growth, these might be for you

Here are 4 of Jim Cramer’s top stock picks for 2022 — if you’re a risk-averse investor but still want solid growth, these might be for you

In December, Mad Money host Jim Cramer told members of the CNBC Investing Club that 2022 is the year “to own companies that make stuff, that do tangible things, that innovate.”

Now that the calendar’s flipped and growth stocks are slumping a bit, putting your money behind established companies that create unique, in-demand products makes an awful lot of sense.

Cramer recently announced his top stock picks for 2022. True to his word, there isn’t an overhyped tech unicorn in the bunch.

Let’s find out why the prognosticator believes so strongly in these four companies.

Honeywell (HON)

s_bukley/Shutterstock

“At this point in the business cycle, the playbook says you have to go with more tangible companies that make real things and generate real profits,” Cramer said last week on CNBC.

One company he feels fits that bill is Fortune 100 mainstay Honeywell. (The company was ranked 94 in 2021.)

As a global industrial conglomerate, Honeywell provides an attractively diversified mix of services and products that range from aerospace and building technologies to safety and productivity solutions.

Despite a snarled global supply chain and decreased demand from its deep-pocketed airline customers, Q3 2021 saw Honeywell increase sales by 8% year over year. Earnings per share increased by 29% over the same period.

Bausch Health Companies (BHC)

Kate Krav-Rude/Shutterstock

Bausch Health is a Canadian pharmaceutical company that develops, manufactures and markets pharma products and branded generic drugs that target a wide variety of health disorders.

Pharma and healthcare companies are always intriguing plays during times of high inflation, as their products remain in demand even if prices rise.

Cramer, however, is most excited by the fact that Bausch plans on breaking itself into three separate entities: eye health, medical aesthetics and pharmaceuticals.

“I like a big breakup story,” he said during a recent episode of Halftime Report….

..

Read More

Recommended For You

Leave a Reply

Your email address will not be published.